FEB 02, 2021 8:00 AM PST

Tumors Under Seige by Cancer-Killing Salmonella

WRITTEN BY: Tara Fernandez

Salmonella is a genus of rod-shaped bacteria, often given a bad rap thanks to its association with food poisoning.

But could salmonella also be our ally in the battle against cancer? Yes, say cancer researchers at the University of Missouri, who have created a safe, genetically-engineered strain of the bacteria that selectively swarms into tumors and directs the body’s immune system while delivering anticancer drugs to eliminate the cancerous masses.

Microscopic analyses of cancerous tissues have revealed an interesting phenomenon—T cells that are supposed to destroy cancer cells instead coexist peacefully with them, mistaking the cancer cells for healthy tissues. 

“Normal cells put up a ‘don’t-eat-me’ molecular flag that is recognized by immune cells, thereby preventing destruction of normal tissues,” explained Yves Chabu, the lead researcher on the study. “But some cancers have also developed the ability to mimic normal cells and produce this ‘don’t eat me’ signal. As a consequence, the immune system fails to recognize the cancer as a defective tissue and leaves it alone, which is bad news for the patient.”

Chabu and team hypothesized that bacteria could help unmask these dangerous malignancies hiding in plain sight. 

“Imagine a patient whose cancer isn’t responding to traditional therapies and has no other treatment options,” said Chabu.

“One can envision genetically modifying the bacteria such that it can unload therapeutics that specifically exploit that cancer’s unique vulnerabilities and kill it.” This hypothesis led Chabu and colleagues to the development of the cancer-killing salmonella strain called CRC2631. Amazingly, the origins of this strain stem from a sample of salmonella that had been stored at room temperature for over 50 years. 

The team is now testing CRC2631’s potential as a weapon against cancers. These are a huge step-up from conventional chemotherapeutic approaches; bombarding the body with chemicals that non-specifically destroy any dividing cells generates many unintended side effects.

Cancer-swarming bacteria are different, says Chabu. “Because CRC2631 preferentially colonizes tumor cells, the effect is mainly localized to the tumor.” 

Previous efforts to genetically engineer bacterial species that can achieve this cancer-specific cell killing have not always been successful, with ongoing struggles around safety and efficacy thwarting progress.

“The use of CRC2631 to design and deliver patient-tailored therapeutics foretells potential in precision medicine, or the ability to tailor a treatment to a specific patient,” said Chabu, who together with his team, continues to drive CRC2631 towards clinical translation.

 

 

Sources: University of Missouri, Oncotarget

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 13, 2020
Cell & Molecular Biology
The Immune Response to Infection and Vaccination Depends on Previous Infections
DEC 13, 2020
The Immune Response to Infection and Vaccination Depends on Previous Infections
After we are exposed to a pathogen or in the case of vaccines, a portion of a pathogen, our body mounts an immune respon ...
DEC 28, 2020
Genetics & Genomics
Mapping Networks of Gene Expression in Cells
DEC 28, 2020
Mapping Networks of Gene Expression in Cells
Every cell contains our whole genome, but not all genes are turned on all the time; gene expression has to be very caref ...
JAN 18, 2021
Immunology
Arthritis Drug Approved for Critically Ill COVID Patients
JAN 18, 2021
Arthritis Drug Approved for Critically Ill COVID Patients
Critically ill COVID patients in the U.K. may receive an arthritis drug after a study showed that treatment lowered mort ...
JAN 28, 2021
Immunology
Killers With a Hit on the Spike
JAN 28, 2021
Killers With a Hit on the Spike
Natural killer cells, or NK cells, are specialized immune cells of the innate immune system. Their job revolves around e ...
APR 13, 2021
Immunology
The "Unexpected" Reason Why COVID Antivirals Don't Work
APR 13, 2021
The "Unexpected" Reason Why COVID Antivirals Don't Work
Purdue University researchers have made a breakthrough finding that could explain why the disease is so hard to manage t ...
APR 15, 2021
Immunology
COVID Vaccines Protect Breastfeeding Babies Too
APR 15, 2021
COVID Vaccines Protect Breastfeeding Babies Too
Good news for families of newborns: A new study shows that breastfeeding mothers who receive a COVID vaccine share prote ...
Loading Comments...